Genetics of Type 2 Diabetes: Past, Present, and Future

被引:40
|
作者
Laakso, Markku [1 ,2 ]
Silva, Lilian Fernandes [1 ]
机构
[1] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio 70210, Finland
[2] Kuopio Univ Hosp, Dept Med, Kuopio 70210, Finland
关键词
type; 2; diabetes; genetics; genome-wide association studies; precision medicine; GENOME-WIDE ASSOCIATION; LARGE-SCALE ASSOCIATION; CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; LOW-FREQUENCY; MENDELIAN RANDOMIZATION; SUSCEPTIBILITY LOCI; PRECISION MEDICINE; GLYCEMIC TRAITS;
D O I
10.3390/nu14153201
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Diabetes has reached epidemic proportions worldwide. Currently, approximately 537 million adults (20-79 years) have diabetes, and the total number of people with diabetes is continuously increasing. Diabetes includes several subtypes. About 80% of all cases of diabetes are type 2 diabetes (T2D). T2D is a polygenic disease with an inheritance ranging from 30 to 70%. Genetic and environment/lifestyle factors, especially obesity and sedentary lifestyle, increase the risk of T2D. In this review, we discuss how studies on the genetics of diabetes started, how they expanded when genome-wide association studies and exome and whole-genome sequencing became available, and the current challenges in genetic studies of diabetes. T2D is heterogeneous with respect to clinical presentation, disease course, and response to treatment, and has several subgroups which differ in pathophysiology and risk of micro- and macrovascular complications. Currently, genetic studies of T2D focus on these subgroups to find the best diagnoses and treatments for these patients according to the principles of precision medicine.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
    Vincent, Emma E.
    Yaghootkar, Hanieh
    DIABETOLOGIA, 2020, 63 (09) : 1706 - 1717
  • [42] Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future
    Mallik, Ritwika
    Chowdhury, Tahseen A.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [43] The present and future treatment of pediatric type 2 diabetes
    Van Name, Michelle Anne
    Guandalini, Cindy
    Steffen, Amy
    Patel, Anisha
    Tamborlane, William
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2018, 13 (04) : 207 - 212
  • [44] Gastric Bypass and Diabetes: Past, Present and Future
    Lee, Tse-I
    Chen, Jui-Hung
    Weng, Ting-Chia
    Chong, Keong
    Lee, Wei-Jei
    Chuang, Lee-Ming
    CURRENT DIABETES REVIEWS, 2011, 7 (05) : 305 - 312
  • [45] Genetics of Type 2 Diabetes: the Power of Isolated Populations
    Andersen, Mette Korre
    Pedersen, Casper-Emil Tingskov
    Moltke, Ida
    Hansen, Torben
    Albrechtsen, Anders
    Grarup, Niels
    CURRENT DIABETES REPORTS, 2016, 16 (07)
  • [46] Hypertension genetics past, present and future applications
    Olczak, Kaya J.
    Taylor-Bateman, Victoria
    Nicholls, Hannah L.
    Traylor, Matthew
    Cabrera, Claudia P.
    Munroe, Patricia B.
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (06) : 1130 - 1152
  • [47] The genetics of schizophrenia: past, present, and future concepts
    DeLisi, LE
    SCHIZOPHRENIA RESEARCH, 1997, 28 (2-3) : 163 - 175
  • [48] Genetics and type 2 diabetes in youth
    Gill-Carey, Olivia
    Hattersley, Andrew T.
    PEDIATRIC DIABETES, 2007, 8 : 42 - 47
  • [49] Genetics of type 1 diabetes
    Redondo, Maria J.
    Steck, Andrea K.
    Pugliese, Alberto
    PEDIATRIC DIABETES, 2018, 19 (03) : 346 - 353
  • [50] Pueraria lobata for Diabetes Mellitus: Past, Present and Future
    Yang, Lihong
    Chen, Jing
    Lu, Huanyu
    Lai, Jiaqi
    He, Yihan
    Liu, Shaonan
    Guo, Xinfeng
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2019, 47 (07): : 1419 - 1444